Newstral
Article
thelocal.ch on 2018-03-27 11:51
Swiss pharma Novartis sells stake in joint venture to GSK for $13bn
Related news
- Novartis sells joint venture stake to GSK for $13 billionsanluisobispo.com
- FNovartis sells stake in joint venture to GSK for $13bnft.com
- Novartis sells stake in consumer business to GSK for $13bnbizjournals.com
- FNovartis sells stake in consumer unit to GSK for $13bnft.com
- Novartis sells consumer healthcare division to GSK in $13bn dealtimesofmalta.com
- GSK & Novartis Try Swapping SuccessWHIO
- WGSK, Novartis wrap up $21B asset swap, form joint venturewraltechwire.com
- NGSK, Pfizer team on over-the-counter drug joint venturenypost.com
- FGSK-Novartis deal ‘a model’ for industryft.com
- GSK sees drop in earnings after asset swap with Novartisreviewtimes.com
- FGSK to sell Aspen stake for almost £574mft.com
- Swiss pharma giant Novartis holds off US price hikes amidst pressure from President Trumpthelocal.ch
- GSK turns around sales of former Novartis meningitis vaccinenewsobserver.com
- Swiss pharma Novartis sees drop in profitsthelocal.ch
- Ionis signs large pharma deal with Novartissandiegouniontribune.com